HPV vaccine study for healthy girls and young women
Part of Cancer, Infections, Skin, Women’s health & pregnancy clinical trials.
This trial studies whether a quadrivalent HPV vaccine is safe and helps the body build protection (immunity) against HPV. It enrolls healthy Chinese females who are not already treated for HPV-related infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy Chinese girl or young woman (about ages 9 to 26)
- You (and if under 18, a parent/guardian) agree to join and sign consent
- If you could become pregnant: you must use effective birth control and test negative for pregnancy on the day of enrollment
- You should not have a fever on the day of enrollment
- You can understand the study and agree to attend regular follow-up visits
- You must not have had HPV vaccination or other HPV vaccine studies during this time period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
This study checks how well the HPV (cancer-preventing) vaccine protection stays in your body over time. It may help confirm the vaccine’s “long-lasting” immune response and guide future vaccination confidence.
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This study tests a 9-valent HPV vaccine (protects against 9 types of human papillomavirus) in women who have already completed a previous HPV vaccine series. Researchers will check how safe the new vaccine is and how well your immune system responds to it.
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
Hear when a new Cervical Cancer Stage IIa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.